A groundbreaking study published in Nature has revealed a new and alarming link between bacteria and aggressive cases of colon cancer. The study found that a bacterium typically associated with dental plaque, Fusobacterium nucleatum, may be behind the rise in treatment-resistant forms of colorectal cancer.
Colon cancer is the second-leading cause of cancer deaths in the US, with over 53,000 expected to die from the disease in 2024. Rates of colon cancer are on the rise among younger individuals, with cases often diagnosed at later and more aggressive stages. Experts are struggling to explain this increase, but the new study suggests that the presence of Fusobacterium nucleatum may play a significant role.
The study found that this specific bacterium shields tumor cells from cancer-fighting drugs, leading to a worse prognosis and poor response to chemotherapy. In some cases, the bacteria may even be responsible for the formation of cancer in the first place. Researchers also discovered that Fusobacterium nucleatum can survive the journey through the stomach and affect the colon, further exacerbating the growth of colorectal cancer.
These findings have significant implications for targeted therapies and treatment approaches. Antibiotic treatment prior to chemotherapy may improve response rates in patients, and identifying dangerous bacterial subspecies could allow for a more targeted approach to treatment. There is even potential for prevention by identifying the bacteria in the mouth and administering antibiotics.
Additionally, the study suggests that new antibiotics targeting specific bacterial subtypes may be developed. There is also the possibility of genetically modifying bacteria to carry cancer-fighting drugs directly into tumors. The role of the microbiome in cancer risk is a growing area of research, and understanding the role of bacteria in colorectal cancer could lead to new treatment approaches and screenings for the disease.
As rates of colon cancer continue to rise, particularly among younger individuals, the discovery of this link between bacteria and aggressive forms of the disease could be a game-changer in the fight against colorectal cancer. Further research in this area may provide new insights and innovative treatment options for patients battling this deadly disease.
“Travel aficionado. Incurable bacon specialist. Tv evangelist. Wannabe internet enthusiast. Typical creator.”